Diabatix is pleased to announce the appointment of Roger Assaker as Chairman of the Board.

Roger Assaker is a serial entrepreneur and business angel investor with an optimal mix of technology (PhD in Aerospace Engineering), business (MBA), and the leadership experience needed to build and commercialize innovative companies and solutions. Before starting MDsim in October 2022, Roger founded e-Xstream engineering in 2003, which he grew into the world leader in advanced material modeling. This success eventually led to its acquisition by MSC Software, a pioneer in Computer Modeling & Simulation and now part of Hexagon.

In early 2020, Roger became the CEO of MSC Software, leading 2000 associates and generating multi-100 million euros in global sales. In 2022, Roger stepped down from his CEO position at MSC to focus on computer modeling and AI applied to medical technology, with a mission to improve the lives of millions of patients. He currently invests in three medical start-ups and scale-ups, including two in silico medtech companies where he serves on the board, along with two additional start-ups.

Recognized for his leadership and innovation, Roger has received numerous honors, including the Creative Young Entrepreneur Award and multiple business plan awards. He has a proven track record of driving cutting-edge R&D in materials engineering, holding several patents and publishing in the fields of fatigue modeling and composite materials. Roger holds a PhD in Applied Sciences and an MBA in International Business, and has completed executive education programs at Harvard and MIT.

Image: source.